163 related articles for article (PubMed ID: 37078167)
1. Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study.
Mei ZF; Yan J; Qian L; He YC; Feng JJ; Wang J; Jie ZJ; Zou H
Technol Cancer Res Treat; 2023; 22():15330338231167827. PubMed ID: 37078167
[TBL] [Abstract][Full Text] [Related]
2. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
3. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
4. The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis.
Guo S; Chen J; Hu P; Li C; Wang X; Chen N; Sun J; Wang Y; Wang J; Gu W; Wu S
Technol Cancer Res Treat; 2023; 22():15330338231166754. PubMed ID: 37093867
[TBL] [Abstract][Full Text] [Related]
5. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
6. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
7. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
[TBL] [Abstract][Full Text] [Related]
9. Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer.
Qiu X; Zhang H; Zhao Y; Zhao J; Wan Y; Li D; Yao Z; Lin D
J Cancer Res Clin Oncol; 2022 Mar; 148(3):685-695. PubMed ID: 33893839
[TBL] [Abstract][Full Text] [Related]
10. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
Lian H; Ding Z; Yuan D; Ma J; Qin J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
[TBL] [Abstract][Full Text] [Related]
12. FlowCell-enriched circulating tumor cells as a predictor of lung cancer metastasis.
Lu Y; Zheng Y; Wang Y; Gu D; Zhang J; Liu F; Chen K; Guo L
Hum Cell; 2021 May; 34(3):945-951. PubMed ID: 33580470
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
[No Abstract] [Full Text] [Related]
14. Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients.
Ji JL; Jiang YZ; Tang QQ; He XD; Shen ZJ; Zhang BY
J Clin Lab Anal; 2016 Sep; 30(5):656-62. PubMed ID: 26987307
[TBL] [Abstract][Full Text] [Related]
15. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW
PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
Ni J; Guo Z; Zhang L
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
[TBL] [Abstract][Full Text] [Related]
18. Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Cao YT; Li JH; Wang YT; Fu YW; Xu J
Tumori; 2014; 100(2):214-8. PubMed ID: 24852868
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
Carlsson A; Nair VS; Luttgen MS; Keu KV; Horng G; Vasanawala M; Kolatkar A; Jamali M; Iagaru AH; Kuschner W; Loo BW; Shrager JB; Bethel K; Hoh CK; Bazhenova L; Nieva J; Kuhn P; Gambhir SS
J Thorac Oncol; 2014 Aug; 9(8):1111-9. PubMed ID: 25157764
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
Breitenbuecher F; Hoffarth S; Worm K; Cortes-Incio D; Gauler TC; Köhler J; Herold T; Schmid KW; Freitag L; Kasper S; Schuler M
PLoS One; 2014; 9(1):e85350. PubMed ID: 24465542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
